149 related articles for article (PubMed ID: 24394545)
1. Inhibitions of the translocation pore of Clostridium botulinum C2 toxin by tailored azolopyridinium salts protects human cells from intoxication.
Bronnhuber A; Maier E; Riedl Z; Hajós G; Benz R; Barth H
Toxicology; 2014 Feb; 316():25-33. PubMed ID: 24394545
[TBL] [Abstract][Full Text] [Related]
2. FK506-binding protein 51 interacts with Clostridium botulinum C2 toxin and FK506 inhibits membrane translocation of the toxin in mammalian cells.
Kaiser E; Böhm N; Ernst K; Langer S; Schwan C; Aktories K; Popoff M; Fischer G; Barth H
Cell Microbiol; 2012 Aug; 14(8):1193-205. PubMed ID: 22420783
[TBL] [Abstract][Full Text] [Related]
3. The host cell chaperone Hsp90 is essential for translocation of the binary Clostridium botulinum C2 toxin into the cytosol.
Haug G; Leemhuis J; Tiemann D; Meyer DK; Aktories K; Barth H
J Biol Chem; 2003 Aug; 278(34):32266-74. PubMed ID: 12805360
[TBL] [Abstract][Full Text] [Related]
4. Cellular uptake of Clostridium botulinum C2 toxin: membrane translocation of a fusion toxin requires unfolding of its dihydrofolate reductase domain.
Haug G; Wilde C; Leemhuis J; Meyer DK; Aktories K; Barth H
Biochemistry; 2003 Dec; 42(51):15284-91. PubMed ID: 14690438
[TBL] [Abstract][Full Text] [Related]
5. Clostridium botulinum C2 toxin: low pH-induced pore formation is required for translocation of the enzyme component C2I into the cytosol of host cells.
Blöcker D; Pohlmann K; Haug G; Bachmeyer C; Benz R; Aktories K; Barth H
J Biol Chem; 2003 Sep; 278(39):37360-7. PubMed ID: 12869543
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine derivatives block the translocation pores and inhibit cellular entry of Clostridium botulinum C2 toxin and Bacillus anthracis lethal toxin.
Kreidler AM; Benz R; Barth H
Arch Toxicol; 2017 Mar; 91(3):1431-1445. PubMed ID: 27106023
[TBL] [Abstract][Full Text] [Related]
7. Cyclophilin A facilitates translocation of the Clostridium botulinum C2 toxin across membranes of acidified endosomes into the cytosol of mammalian cells.
Kaiser E; Pust S; Kroll C; Barth H
Cell Microbiol; 2009 May; 11(5):780-95. PubMed ID: 19159389
[TBL] [Abstract][Full Text] [Related]
8. Cyclophilin-facilitated membrane translocation as pharmacological target to prevent intoxication of mammalian cells by binary clostridial actin ADP-ribosylated toxins.
Ernst K; Langer S; Kaiser E; Osseforth C; Michaelis J; Popoff MR; Schwan C; Aktories K; Kahlert V; Malesevic M; Schiene-Fischer C; Barth H
J Mol Biol; 2015 Mar; 427(6 Pt A):1224-38. PubMed ID: 25058685
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine Analog Interaction with C2- and Iota-Toxin in Vitro and in Living Cells.
Kronhardt A; Beitzinger C; Barth H; Benz R
Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27517960
[TBL] [Abstract][Full Text] [Related]
10. Formation of a biologically active toxin complex of the binary Clostridium botulinum C2 toxin without cell membrane interaction.
Kaiser E; Haug G; Hliscs M; Aktories K; Barth H
Biochemistry; 2006 Nov; 45(44):13361-8. PubMed ID: 17073457
[TBL] [Abstract][Full Text] [Related]
11. Intracellular trafficking of Clostridium botulinum C2 toxin.
Nagahama M; Takahashi C; Aoyanagi K; Tashiro R; Kobayashi K; Sakaguchi Y; Ishidoh K; Sakurai J
Toxicon; 2014 May; 82():76-82. PubMed ID: 24582943
[TBL] [Abstract][Full Text] [Related]
12. EGA Protects Mammalian Cells from Clostridium difficile CDT, Clostridium perfringens Iota Toxin and Clostridium botulinum C2 Toxin.
Schnell L; Mittler AK; Sadi M; Popoff MR; Schwan C; Aktories K; Mattarei A; Azarnia Tehran D; Montecucco C; Barth H
Toxins (Basel); 2016 Apr; 8(4):101. PubMed ID: 27043629
[TBL] [Abstract][Full Text] [Related]
13. The Pore-Forming Subunit C2IIa of the Binary
Eisele J; Schreiner S; Borho J; Fischer S; Heber S; Endres S; Fellermann M; Wohlgemuth L; Huber-Lang M; Fois G; Fauler M; Frick M; Barth H
Front Pharmacol; 2022; 13():810611. PubMed ID: 35222028
[TBL] [Abstract][Full Text] [Related]
14. The binary Clostridium botulinum C2 toxin as a protein delivery system: identification of the minimal protein region necessary for interaction of toxin components.
Barth H; Roebling R; Fritz M; Aktories K
J Biol Chem; 2002 Feb; 277(7):5074-81. PubMed ID: 11741886
[TBL] [Abstract][Full Text] [Related]
15. Combined Pharmacological Inhibition of Cyclophilins, FK506-Binding Proteins, Hsp90, and Hsp70 Protects Cells From
Ernst K; Kling C; Landenberger M; Barth H
Front Pharmacol; 2018; 9():1287. PubMed ID: 30483129
[TBL] [Abstract][Full Text] [Related]
16. Channel formation by the binding component of Clostridium botulinum C2 toxin: glutamate 307 of C2II affects channel properties in vitro and pH-dependent C2I translocation in vivo.
Blöcker D; Bachmeyer C; Benz R; Aktories K; Barth H
Biochemistry; 2003 May; 42(18):5368-77. PubMed ID: 12731878
[TBL] [Abstract][Full Text] [Related]
17. Tailored ß-cyclodextrin blocks the translocation pores of binary exotoxins from C. botulinum and C. perfringens and protects cells from intoxication.
Nestorovich EM; Karginov VA; Popoff MR; Bezrukov SM; Barth H
PLoS One; 2011; 6(8):e23927. PubMed ID: 21887348
[TBL] [Abstract][Full Text] [Related]
18. Clostridium botulinum C2 toxin--new insights into the cellular up-take of the actin-ADP-ribosylating toxin.
Aktories K; Barth H
Int J Med Microbiol; 2004 Apr; 293(7-8):557-64. PubMed ID: 15149031
[TBL] [Abstract][Full Text] [Related]
19. Cellular uptake of Clostridium botulinum C2 toxin requires oligomerization and acidification.
Barth H; Blocker D; Behlke J; Bergsma-Schutter W; Brisson A; Benz R; Aktories K
J Biol Chem; 2000 Jun; 275(25):18704-11. PubMed ID: 10749859
[TBL] [Abstract][Full Text] [Related]
20. Genetically engineered clostridial C2 toxin as a novel delivery system for living mammalian cells.
Fahrer J; Plunien R; Binder U; Langer T; Seliger H; Barth H
Bioconjug Chem; 2010 Jan; 21(1):130-9. PubMed ID: 20030334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
